Skip to main content
Annotating MYC status with 89Zr-transferrin imaging.
Published Web Location
http://europepmc.org/articles/PMC3521603?pdf=renderNo data is associated with this publication.
Abstract
A noninvasive technology that quantitatively measures the activity of oncogenic signaling pathways could have a broad impact on cancer diagnosis and treatment with targeted therapies. Here we describe the development of (89)Zr-desferrioxamine-labeled trans
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.